Genesis Biopharma Inc

-

Stock Issuer and Owners

Home | Sign Up | Log In
Message
Happy Holidays!! thanks for using AUM13F!!
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Genesis Biopharma Inc
TickerIOVA
CIK #0001425205
CUSIP462260100
SectorEnergy & Transportation - Arrangement Of Transportation Of Freight & Cargo
Address1601 N Sepulveda Blvd, #632, Manhattan Beach, CA 90266
Source [EDGAR]
CIK Filing 2011 - 2025
[0001425205] 10-K
[0001425205] 10-Q
[0001425205] 3
[0001425205] 4
[0001425205] 5
[0001425205] 8-K
[0001425205] D
[0001425205] SC 13D
[0001425205] SC 13G
Form 13D/13G Filer Form 13D/13G Subject Filed % Owned
Perceptive Advisors LLC Iovance Biotherapeutics Inc [2024-03-01] 81946.9
Point72 Asset Management LP Iovance Biotherapeutics Inc [2023-02-17] 4.6
BlackRock Inc Iovance Biotherapeutics Inc [2023-02-03] 7.7
State Street Corp Iovance Biotherapeutics Inc [2023-02-02] 9.32
MHR Fund Management LLC Iovance Biotherapeutics Inc [2022-12-30] 5.8
Wellington Management Group LLP Iovance Biotherapeutics Inc [2022-02-04] 6.11
ARK Investment Management LLC Iovance Biotherapeutics Inc [2021-01-11] 10.43
Price T Rowe Associates Inc /MD/ Iovance Biotherapeutics Inc [2020-02-14] 5.1
Vanguard Group Inc Iovance Biotherapeutics Inc [2020-02-11] 8.6
Acuta Capital Partners LLC Iovance Biotherapeutics Inc [2019-02-14] 2.5
Perceptive Advisors LLC Iovance Biotherapeutics Inc [2019-02-14] 9.9
Acuta Capital Partners LLC Iovance Biotherapeutics Inc [2018-02-14] 5.4
Broadfin Capital LLC Iovance Biotherapeutics Inc [2018-02-13] 6.75
BlackRock Inc Iovance Biotherapeutics Inc [2018-01-25] 6.7
Acuta Capital Partners LLC Lion Biotechnologies Inc [2017-02-13] 6.1
OrbiMed Advisors LLC Lion Biotechnologies Inc [2017-02-13] 3.92
Franklin Resources Inc Lion Biotechnologies Inc [2017-02-07] 8.4
Quogue Capital LLC Lion Biotechnologies Inc [2016-06-13] 0.6
RS Investment Management Co LLC Lion Biotechnologies Inc [2016-02-12] 5.55
venBio Select Advisor LLC Lion Biotechnologies Inc [2016-02-12] 6.7
Broadfin Capital LLC Lion Biotechnologies Inc [2016-02-11] 7.31
BlackRock Inc Lion Biotechnologies Inc [2016-01-28] 6.6
Perceptive Advisors LLC Lion Biotechnologies Inc [2015-02-17] 0.76
FMR LLC Lion Biotechnologies Inc [2014-07-10] 0.0
Alpha Capital Anstalt Lion Biotechnologies Inc [2014-01-02] 7.197
Ayer Capital Management LP Genesis Biopharma Inc [2013-06-03] 40.47
[2013-01-09] None
Form 3/4/5 Filer 2011 - 2025
Iovance Biotherapeutics Inc
Roche Corleen M.
Rosinack Matthew W.
Weiser Michael
Dukes Iain D.
Yarno Wendy L
Countouriotis Athena
Maynard Ryan D
Kirby Daniel Gordon
Bellemin Jean-Marc
Puri Raj K.
Vogt Frederick G
Graf Finckenstein Friedrich
Bilinsky IGOR
Rothbaum Wayne P.
McPeak Merrill A
Dixon Wendy L
Swartzburg Michael
Fardis Maria
Morris Timothy E
Hillsberg Sanford
Venkatesan Jay
Valle Franco
Schiffman Gregory T
Henderson Molly
Fischkoff Steven A.
Lotze Michael
Hawkins ELMA
Bender James G.
ACM Capital Partners, LLC
Ayer Capital Management, LP
Ayer Capital Partners, LLC
Radvanyi Laszlo
Handelman Michael D
Bristol Investment Fund Ltd
Bristol Capital LLC
Singh Manish
Voyticky David J
Kessler Paul L
Form 13F Holdings
Firm Period DFND Voting Shares
MHR Fund Management LLC [2025-06-30] SOLE 28,967,103 28,967,103
Vanguard Group Inc [2025-06-30] SOLE 0 24,600,993
BlackRock, Inc. [2025-06-30] SOLE 22,385,419 23,236,812
Long Focus Capital Management LLC [2025-06-30] SOLE 11,820,000 11,820,000
State Street Corp [2025-06-30] DFND 9,209,378 9,890,525
Millennium Management LLC [2025-06-30] SOLE 9,330,223 9,330,223
Invenomic Capital Management LP [2025-06-30] SOLE 8,294,663 8,294,663
Morgan Stanley [2025-06-30] DFND 6,091,118 6,450,933
Geode Capital Management LLC [2025-06-30] DFND 6,189,058 6,189,058
Citadel Advisors LLC [2025-06-30] DFND 5,120,188 5,120,188
Renaissance Technologies LLC [2025-06-30] SOLE 4,887,200 4,887,200
Goldman Sachs Group Inc [2025-06-30] DFND 4,704,423 4,749,876
Two Sigma Investments LP [2025-06-30] SOLE 4,633,451 4,633,451
Principal Financial Group Inc [2025-06-30] DFND 4,601,441 4,601,441
Bank of America Corp /DE/ [2025-06-30] DFND 1,164,726 4,029,568
Palo Alto Investors LP [2025-06-30] SOLE 3,429,329 3,429,329
Soleus Capital Management LP [2025-06-30] SOLE 3,261,707 3,261,707
Susquehanna International Group LLP [2025-06-30] OTR 2,071,472 2,936,172
Dimensional Fund Advisors LP [2025-06-30] SOLE 2,462,497 2,684,753
Royal Bank of Canada [2025-06-30] DFND 2,341,083 2,359,530
Orion Investment Co [2025-06-30] SOLE 0 2,338,563
Two Sigma Advisers LP [2025-06-30] SOLE 2,293,000 2,334,900
Jane Street Group LLC [2025-06-30] DFND 2,073,871 2,314,471
Northern Trust Corp [2025-06-30] DFND 2,075,680 2,078,903
Charles Schwab Investment Management Inc [2025-06-30] SOLE 1,916,486 1,916,486
Price T Rowe Associates Inc /MD/ [2025-06-30] SOLE 1,866,411 1,866,411
Tang Capital Management LLC [2025-06-30] OTR 0 1,800,000
UBS Group AG [2025-06-30] DFND 1,671,802 1,779,412
Rice Hall James & Associates LLC [2025-06-30] SOLE 1,243,514 1,591,575
Balyasny Asset Management LP [2025-06-30] SOLE 1,507,782 1,507,782
Prev | Page 3 | Next
Terms | Privacy | Guide
tony@aum13f.com